+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Using stem cell biology to design precision medicine for non-small cell lung cancer

Using stem cell biology to design precision medicine for non-small cell lung cancer

Journal of Thoracic Oncology 11(2): S4-S5

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 064940927

Download citation: RISBibTeXText

DOI: 10.1016/j.jtho.2015.12.006

Related references

Non-small cell lung cancer and precision medicine: a model for the incorporation of genomic features into clinical trial design. JAMA 311(19): 1975-1976, 2014

Precision radiotherapy for patients with locally advanced non-small cell lung cancer in the era of immunotherapy and precision medicine. Translational Lung Cancer Research 7(Suppl 2): S146, 2018

Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer. Frontiers in Medicine 4: 39, 2017

Advances in molecular biology of lung disease: aiming for precision therapy in non-small cell lung cancer. Chest 148(4): 1063-1072, 2015

Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer. Current Pharmaceutical Design 22(28): 4374-4385, 2016

Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib. Medical Oncology 35(5): 72, 2018

Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer. Pharmacogenomics and Personalized Medicine 7: 285-295, 2014

Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR. Pharmacogenomics and Personalized Medicine 8: 63-79, 2015

Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine. Current Treatment Options in Oncology 19(8): 43, 2018

Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?. Translational Lung Cancer Research 4(6): 797-800, 2015

Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer. Clinical and Translational Medicine 6(1): 7, 2017

Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker Interpretation. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting 38: 708-715, 2018

Studies on cell biology and chemotherapy of lung cancer using tissue culture techniques: Part 2. Biological characteristics of five newly established small cell lung cancer cell lines. Okayama Igakkai Zasshi 104(9-10): 905-913, 1992

Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials. Journal of Clinical Oncology 11(9): 1757-1762, 1993

Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine. Clinical Chemistry and Laboratory Medicine 55(12): 1817-1833, 2017